NFA
IDIX

Nationwide Fund Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Nationwide Fund Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-90,248
Closed -$2.17M – 3410
2014
Q2 		$2.17M Buy
90,248
+9,252
+11% +$96.4K 0.01% 1432
2014
Q1 		$488K Buy
80,996
+3,904
+5% +$27.2K ﹤0.01% 2073
2013
Q4 		$461K Sell
77,092
-12,286
-14% -$56.8K ﹤0.01% 2284
2013
Q3 		$466K Buy
89,378
+17,993
+25% +$78.8K ﹤0.01% 2258
2013
Q2 		$258K Buy
+71,385
New +$292K ﹤0.01% 2369

Nationwide Fund Advisors's IDIX Position: Q3 2014 in Review

Nationwide Fund Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 90,248 shares — an estimated $2.17M sold.

Nationwide Fund Advisors first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $2.17M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Nationwide Fund Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Nationwide Fund Advisors sold 90,248 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.17M.
  • Nationwide Fund Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Nationwide Fund Advisors's IDENIX PHARMACEUTICALS INC position peaked at $2.17M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Nationwide Fund Advisors's 13F filing for Q3 2014, filed 7 Nov 2014.